Amanote Research
Register
Sign In
Incidence and Consequence of Close Margins in Patients With Ductal Carcinoma-In Situ Treated With Mastectomy: Is Further Therapy Warranted?
Breast Diseases
- United States
doi 10.1016/j.breastdis.2014.10.018
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Surgery
Date
January 1, 2014
Authors
D. Sarma
E.S. Hwang
Publisher
Elsevier BV
Related search
Is Sentinel Lymph Node Dissection Warranted for Patients With a Diagnosis of Ductal Carcinoma in Situ?
Annals of Surgical Oncology
Oncology
Surgery
Treatment Results in Patients With Ductal Carcinoma in Situ Treated With Adjuvant Radiotherapy
Turkish Journal of Medical Sciences
Medicine
The Association of Surgical Margins and Local Recurrence in Women With Ductal Carcinoma in Situ Treated With Breast-Conserving Therapy: A Meta-Analysis
Annals of Surgical Oncology
Oncology
Surgery
Utilization of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma in Situ Undergoing Mastectomy
Annals of Surgical Oncology
Oncology
Surgery
Utilization of Lymph Node Assessment in Patients With Ductal Carcinoma in Situ Treated With Lumpectomy
Journal of Surgical Research
Surgery
Current Management of Patients With Ductal Carcinoma‐in‐Situ
Oncologist
Cancer Research
Medicine
Oncology
Tamoxifen Acceptance and Adherence Among Patients With Ductal Carcinoma in Situ (DCIS) Treated in a Multidisciplinary Setting
Cancer Prevention Research
Medicine
Cancer Research
Oncology
Patterns and Correlates of Local Therapy for Women With Ductal Carcinoma-In-Situ
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Different Distribution of Breast Ductal Carcinoma in Situ, Ductal Carcinoma in Situ With Microinvasion, and Invasion Breast Cancer
World Journal of Surgical Oncology
Surgery
Oncology